<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Brain-Penetrating on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/brain-penetrating/</link>
    <description>Recent content in Brain-Penetrating on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 07:59:02 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/brain-penetrating/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer&#39;s Drug</title>
      <link>https://cluster-site.onrender.com/posts/startup-korsana-bio-reveals-175m-raised-for-a-better-brain-penetrating-alzheimers-drug/</link>
      <pubDate>Sun, 22 Feb 2026 14:10:00 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/startup-korsana-bio-reveals-175m-raised-for-a-better-brain-penetrating-alzheimers-drug/</guid>
      <description>• Korsana Biosciences&amp;rsquo; preclinical Alzheimer&amp;rsquo;s disease drug comes from a platform technology that enables antibodies to cross the blood-brain barrier. • Roche and AbbVie have clini</description>
    </item>
  </channel>
</rss>
